Lucy Scientific Discovery is an early-stage psychotropics manufacturing company focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Our mission is to make our products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders. We target customers that include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances. Our executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products. Lucy Scientific Discovery trades on the Nasdaq Capital Market under the symbol LSDI.
Data Provided by Refinitiv. Minimum 15 minutes delayed.